# Eagle Pharmaceuticals

Eagle Pharmaceuticals is an Asset Manager based in Woodcliff Lake, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Woodcliff Lake, United States
- **Region:** North America
- **Address:** Woodcliff Lake, NJ, United States
- **Assets under management:** Undisclosed
- **Website:** eagleus.com

## Regulatory record

- **Reports private funds:** No

## About

Eagle Pharmaceuticals is a specialty pharmaceutical company realizing the untapped potential of life-saving medicines. See what we’re doing to bring brilliant science to life.

## Sectors

- Healthcare Services
- Pharmaceuticals

## Offices

- Cambridge, MA
- Indianapolis, IN

## People

- Michael Graves — Chief Executive Officer & Chairman of the Board
- Christopher Krawtschuk — Chief Financial Officer
- Daniel O'Connor — Chief Strategy Officer, Head of Corporate Development

## Questions

### Is Eagle Pharmaceuticals a private investment fund or an operating company?

Eagle Pharmaceuticals is a publicly traded operating company, not a private investment fund. It is listed on NASDAQ under ticker EGRX and is structured as a specialty pharmaceutical company. The firm discovers, develops, and markets its own branded and generic injectable products directly to healthcare systems, rather than investing capital in external ventures.

### What is Eagle's expertise within the pharmaceutical sector?

The firm concentrates on injectable treatments for critical care and oncology in hospital settings. Its portfolio contains both complex generic injectables and new chemical entities (NCEs). Marketing names such as BYFAVO for procedural sedation and PEMFEXY for oncology reflect a focus on faster or safer administration in acute-care environments.

### Does Eagle Pharmaceuticals operate international subsidiaries or partnerships?

The firm's disclosed physical operations are all within the United States, with offices in New Jersey, Massachusetts, and Indiana. Its public materials cite a collaboration with Teva Pharmaceuticals on a bendamustine injection, but the geographical scope of that partnership is not detailed beyond North American distribution as shown on official packaging.

### Who runs investment decisions at Eagle Pharmaceuticals?

Business development and pipeline strategy are led by CEO Michael Graves and Chief Strategy Officer Daniel O'Connor, who also serves as Head of Corporate Development. Because Eagle is an operating company, investment decisions — such as acquiring or divesting a drug — are made by this leadership team and approved by a board of directors that includes medical scientist Luciana Borio.

## Related profiles

- [The University of Utah](https://altss.com/profile/the-university-of-utah)
- [Hill City Capital](https://altss.com/profile/hill-city-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/eagle-pharmaceuticals

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology